It is now generally accepted that expiratory airflow limitation, persistent or variable, is a useful basis for diagnostic categorization. Dr Geddes describes rules for the management of patients disabled by chronic airflow limitation without feeling the need to mention chronic bronchitis or emphysema. These are the only headings in Davidson's book under which such patients might have been included. Similarly, the possibility that simple measurements related to expiratory airflow resistance, such as the peak expiratory flow-rate, might be found important in the diagnosis of asthma and in assessment of its severity and response to treatment, emphasized by Dr Hetzel, was virtually unsuspected in 1935. In therapy, the only sympathomimetic bronchodilators then available were adrenaline and ephedrine, and corticosteroids were unknown. Adrenaline was first used by subcutaneous injection in asthma about 1900, and this had become a standard procedure for acute episodes. Some physicians used adrenaline by inhalation from a nebulizer, but its value was limited by the nonselectivity of the sympathomimetic effect and by the rapid deterioration of adrenaline in solution. Ephedrine, active by mouth but slower in onset of action, was similarly limited by non-selectivity. Isoprenaline, the first fl-selective sympathomimetic, came into use from 1940 onwards, but it was not until 15 or more years later that the 82-selective agents, now the mainstay of bronchodilator therapy, were introduced. Similarly, it was not until the middle 1950s that corticosteroids were at all widely used in the management of asthma, and 10 years later before they began to be used by inhalation. Theophylline and its derivatives, such as aminophylline, were available and used, especially intravenously for acute episodes, in the 1930s; and it is interesting that although they are still widely used, argument about their place in the treatment of asthma continues.
In lung cancer, the most striking change in the past 50 years has been the enormous increase in its incidence, and the most important advance in knowledge the now incontrovertible evidence that this increase is due to the preceding spread of the cigarette-smoking habit. Dr Spiro notes that the number of deaths among men is now falling, and that this can be accounted for in large part by diminution in cigarette-smoking among men in recent decades. It is depressing that among women the number of deaths is still rising, correlating with the continuing trend towards increased smoking among women. There is no prospect of significant reduction in mortality either by more effective therapy or screening procedures leading to earlier diagnosis; and this makes difficulty and delay in persuading the public generally to take heed of the most important discovery in preventive medicine in our time doubly frustrating. Differences between small-cell and other histological types of carcinoma in response to surgery and radiotherapy and in prognosis have long been evident. The results of surgical treatment, available for only a proportion of patients, and giving its best results in those with squamous-cell tumours, have changed little in the past 30 years and there is little evidence that any hitherto devised scheme of adjuvant radiotherapy, chemotherapy or immunotherapy improves them. The susceptibility of small-cell carcinoma to radiotherapy and to cytotoxic drugs provides a means of short-term palliation in many patients, and the search for combination therapy that may be more effective and lead to more long-term remissions continues; and recognition that small-cell carcinoma is diverse in cell biology holds promise that more selective treatment of different cell-types may lead to better results.
Two recent additions to investigatory procedures, fibreoptic bronchoscopy and computed tomography, are discussed by Drs Dhillon and Collins and by Dr Strickland. In 1935, only the rigid bronchoscope was available, and it was used principally in the diagnosis of malignant disease. Maurice Davidson's book mentions its therapeutic use in lung abscess to aspirate pus and improve drainage. The best comment I remember on this procedure was made by a young man whose chronic lung abscess was being treated by periodic bronchoscopic aspiration under local anaesthetic, which, with the rigid instrument, was a fairly formidable procedure for the patient. On being told at the end of one of these sessions that 2 ounces of pus has been aspirated, he exclaimed, 'But I cough up 5 ounces every day by myself!'. The introduction of the fibreoptic instrument has greatly increased the range of clinical and investigatory applications of bronchoscopy, both because it can be performed under local anaesthetic with levels of discomfort acceptable to most patients, and because it brings more of the bronchial tree into view. The diagnosis of malignant disease remains prominent among its uses; the possibility of safe transbronchial forceps biopsy of the lung extends its uses to the diagnosis of diffuse lung disease; and bronchoalveolar lavage through the fibreoptic bronchoscope has made important contributions to the cellular immunology of the lung.
Conventional tomography did not enter in general use until shortly after the publication of Davidson's book. The technology that made possible the development of computed tomography in 1969 was then undreamt of. The applications of computed tomography to the thorax are still being explored, as Dr Strickland emphasizes. It is already evident that its potential contribution far exceeds that of conventional tomography, and indeed is of a different order, but unfortunately at very much greater cost.
The remaining three contributions concern diseases not mentioned in Maurice Davidson's book, but now of major interest in respiratory medicine. Professor Turner-Warwick discusses the current state of knowledge of pathogenetic mechanisms leading to diffuse pulmonary alveolar fibrosis, and the implications for prognosis and response to corticosteroids. This is an entirely new field since 1935 In the light of this experience, I am disinclined to make any but the most general comments about future trends. It would be pleasant to think that in 50 years' time, it will be possible to look back on a similar diminution in mortality from those respiratory diseases that now cause the greatest numbers of deaths, those characterized by expiratory airflow limitation and lung cancer. But these diseases differ, in a respect highly relevant to this prospect, from those which have come under control in my life-time. The principal causal factor in them, cigarette-smoking, can be dealt with only by avoidance. No known measure can prevent the development of either of them in a susceptible smoker, and it seems very unlikely that any medicament that will protect the continuing smoker from the dangers of persistent airflow limitation, bronchial catarrh, and cancer will be developed. The only way in which mortality from them can be reduced is prevention by the elimination of cigarette-smoking as a socially acceptable habit. Although doctors have the obvious duty of reminding their patients and others, especially those with influence on social policy, constantly of these facts, responsibility for general publicity and other measures aimed at maximizing rational response to them does not seem to me to be a specifically medical one.
Finally, the viability of the National Health Service, or of any other system of medical care, depends upon the development of preventive measures, diminishing the number of people who need medical care, and curative treatment, returning those who do to full health without the need for further medical care; and is threatened by increasing commitment to the palliation of end-stage irreversible disease. Research into ways of alleviating chronic disease must continue, because relief of suffering must remain a major concern; but it should take second place to the study of the earlier stages of disease, aetiology and pathogenesis, which may lead to the possibility of prevention and of curative treatment.
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